SCHEMBL27585045

SCHEMBL27585045

CCC(C=O)C(=O)Oc1nccs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 5/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HTT P42858 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ HSPA5 P11021 1/20 0.34
▸ RAB9A P51151 2/20 0.33
▸ FFAR2 O15552 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13370728 0.77 ALDH1A1 (0.41) PKMALDH1A1HTTMAPTLMNA
SCHEMBL27651626 0.75 ALDH1A1 (0.41) PKMALDH1A1HTTMAPTLMNA
SCHEMBL1133747 0.74 ALDH1A1 (0.40) PKMALDH1A1HTTMAPTLMNA
SCHEMBL27630399 0.74 ALDH1A1 (0.40) PKMALDH1A1HTTMAPTLMNA
SCHEMBL7456124 0.72 ALDH1A1 (0.51) PKMALDH1A1HTTMAPTLMNA
SCHEMBL8701139 0.72 PKM (0.38) PKMALDH1A1HTTMAPTLMNA
SCHEMBL7405770 0.72 HSD17B10 (0.40) ALDH1A1HTTMAPTLMNASMN1; SMN2
SCHEMBL27641755 0.72 ALDH1A1 (0.41) PKMALDH1A1HTTMAPTLMNA
SCHEMBL29053272 0.72 ALDH1A1 (0.38) PKMALDH1A1HTTMAPTLMNA
SCHEMBL2041342 0.72 PKM (0.42) PKMALDH1A1HTTMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1387528-A Heterocyclic substd, pyrazolones CEPHALON INC (US) 2002-12-25 — — CN disclosed
Send feedback